National Bank Of Canada Legend Biotech Corp Transaction History

National Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$33.54 - $55.0 $845,208 - $1.39 Million	25,200 New	25,200 $1.39 Million
Q1 2022 May 05, 2022	SELL	$31.02 - $48.18 $2.21 Million - $3.44 Million	-71,300 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$41.14 - $56.98 $2.93 Million - $4.06 Million	71,300 New	71,300 $3.32 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.5B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.